Bayram, N.N.; Ulu, G.T.; Abdulhadi, N.A.; Gürdap, S.; İşoğlu, İ.A.; Baran, Y.; İşoğlu, S.D.
HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study. Pharmaceutics 2023, 15, 733.
https://doi.org/10.3390/pharmaceutics15030733
AMA Style
Bayram NN, Ulu GT, Abdulhadi NA, Gürdap S, İşoğlu İA, Baran Y, İşoğlu SD.
HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study. Pharmaceutics. 2023; 15(3):733.
https://doi.org/10.3390/pharmaceutics15030733
Chicago/Turabian Style
Bayram, Nazende Nur, Gizem Tuğçe Ulu, Nusaibah Abdulsalam Abdulhadi, Seda Gürdap, İsmail Alper İşoğlu, Yusuf Baran, and Sevil Dinçer İşoğlu.
2023. "HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study" Pharmaceutics 15, no. 3: 733.
https://doi.org/10.3390/pharmaceutics15030733
APA Style
Bayram, N. N., Ulu, G. T., Abdulhadi, N. A., Gürdap, S., İşoğlu, İ. A., Baran, Y., & İşoğlu, S. D.
(2023). HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study. Pharmaceutics, 15(3), 733.
https://doi.org/10.3390/pharmaceutics15030733